Related Experiment Video
Updated: Oct 5, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
[Anticancer properties of flagellate protozoan Trypanosoma cruzi Chagas, 1909]
V D Kallinikova1, P V Matekin, T A Ogloblina
1Moscow State University, Vorob'evy gory, Moscow, 119899 Russia.
Abstract:
The anticancer activity of Trypanosoma cruzi has been confirmed by the example of seven strains. Five virulent strains induced the infection, which inhibited sarcoma-180 growth 1.5-22.0 times. The parasites featured tumortropism; i.e., the successfully developed in cancer cells and even preferred them to normal cells. This taxis-based phenomenon was particularly pronounced at cocultivation of the normal and cancer cells. Cultures of the seven (avirulent and virulent) strains can produce an anticancer agent that selectively damages human cancer cells in vitro. The long-term anticancer effect of T. cruzi or preparations from it, as well as possible its cancer preventing effect, has been demonstrated. Three problems are discussed on the basis of the obtained and recently published data: (1) the mechanism of T. cruzi anticancer effect; (2) the nature of the anticancer agent; and (3) the distribution of the considered phenomenon among trypanosomatides. The anticancer activity of T. cruzi may be due to a combination of surface cellular antigens and an inhibiting or lysing factor.
Insights
Trypanosoma cruzi exhibits anticancer activity, inhibiting tumor growth and selectively damaging cancer cells. This parasite shows promise for cancer prevention and treatment through its unique tumortropism.
Area of Science:
- Parasitology
- Oncology
- Immunology
Context:
- Trypanosoma cruzi, a protozoan parasite, has demonstrated significant anticancer properties.
- Seven strains of T. cruzi were evaluated for their efficacy against sarcoma-180.
- Parasite tumortropism, or preference for cancer cells, was a key observation.
Purpose:
- To confirm and characterize the anticancer activity of Trypanosoma cruzi.
- To investigate the mechanism and nature of the anticancer agent produced by T. cruzi.
- To explore the potential of T. cruzi in cancer prevention and treatment.
Summary:
- Virulent T. cruzi strains inhibited sarcoma-180 growth by 1.5-22.0 times.
- T. cruzi parasites demonstrated tumortropism, preferentially developing in cancer cells.
- T. cruzi cultures produced an anticancer agent selectively damaging human cancer cells in vitro.
- Both long-term anticancer and potential cancer-preventing effects were observed.
Impact:
- T. cruzi presents a novel avenue for cancer therapy development.
- Understanding T. cruzi's anticancer mechanisms could lead to new drug targets.
- The study suggests potential applications of T. cruzi in cancer prevention strategies.
Related Concept Videos
American Trypanosomiasis
Antiprotozoal Agents
Trichomoniasis
Leishmaniasis

